Search research articles
Contact Us
Filters
Showing results (301-310 of 318) with videos related to
Page
of 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2012
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma
John S Jarboe, Joshua C Anderson, Christine W Duarte, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
Steven E Schild, James A Bonner, Thomas G Shanahan, et al.
Oral Oncology
|
March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck
Matthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
Loren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522
Minh Tam Truong, Qiang Zhang, David I Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis
Audrey Mauguen, Cécile Le Péchoux, Michele I Saunders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 318) with videos related to
Sort By:
Page
of 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2012
MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma
John S Jarboe, Joshua C Anderson, Christine W Duarte, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer
Steven E Schild, James A Bonner, Thomas G Shanahan, et al.
Oral Oncology
|
March 9, 2019
A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck
Matthew C Ward, Nancy Y Lee, Jimmy J Caudell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
Loren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2016
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522
Minh Tam Truong, Qiang Zhang, David I Rosenthal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 4, 2012
Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis
Audrey Mauguen, Cécile Le Péchoux, Michele I Saunders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2017
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522
K Kian Ang, Qiang Zhang, David I Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 22, 2018
In Regard to Bossi et al
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, et al.
Journal of Geriatric Oncology
|
April 5, 2021
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer
Julie A Kish, Qiang Zhang, Corey J Langer, et al.
Page
of 32